188 related articles for article (PubMed ID: 37409133)
21. [Characteristics and clinical significance of pulmonary function test and KL-6 in ASSD-ILD and IPF].
Sun D; Cheng Z; Jiang TC; Li PF; Jia LQ; Wang TT; Zheng CP; Li Y; Duo MJ
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(10):748-752. PubMed ID: 32192286
[No Abstract] [Full Text] [Related]
22. Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review.
d'Alessandro M; Bergantini L; Cameli P; Vietri L; Lanzarone N; Alonzi V; Pieroni M; M Refini R; Sestini P; Bonella F; Bargagli E
Biomark Med; 2020 Jun; 14(8):665-674. PubMed ID: 32613855
[No Abstract] [Full Text] [Related]
23. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
24. Serum Rcn3 level is a potential diagnostic biomarker for connective tissue disease-associated interstitial lung disease and reflects the severity of pulmonary function.
Ding F; Yang L; Wang Y; Wang J; Ma Y; Jin J
BMC Pulm Med; 2023 Feb; 23(1):68. PubMed ID: 36800954
[TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of connective tissue disease-associated interstitial lung disease and interstitial pneumonia with autoimmune features.
Tian M; Huang W; Ren F; Luo L; Zhou J; Huang D; Tang L
Clin Rheumatol; 2020 Feb; 39(2):575-583. PubMed ID: 31758424
[TBL] [Abstract][Full Text] [Related]
26. Association of Red Blood Cell Distribution Width Levels with Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD).
Shi S; Chen L; Gui X; Chen L; Qiu X; Yu M; Xiao Y
Dis Markers; 2021; 2021():5536360. PubMed ID: 34457089
[TBL] [Abstract][Full Text] [Related]
27. Lung ultrasound B-lines and serum KL-6 correlate with the severity of idiopathic inflammatory myositis-associated interstitial lung disease.
Wang Y; Chen S; Lin J; Xie X; Hu S; Lin Q; Zheng K; Du G; Huang X; Zhang G; Gargani L; Matucci-Cerinic M; Furst DE
Rheumatology (Oxford); 2020 Aug; 59(8):2024-2029. PubMed ID: 31794028
[TBL] [Abstract][Full Text] [Related]
28. Serum Krebs von den Lungen-6 concentrations reflect severity of anti-melanoma differentiation-associated protein 5 antibody positive dermatomyositis associated interstitial lung disease.
Zhu Y; Wang L; Sun Y; Wang J; Lv C; You H; Xu L; Wang F; Zhang M; Tan W; Ke Y
Clin Exp Rheumatol; 2022 Feb; 40(2):292-297. PubMed ID: 34874831
[TBL] [Abstract][Full Text] [Related]
29. Monitoring small airway dysfunction in connective tissue disease-related interstitial lung disease: a retrospective and prospective study.
Xu L; Sgalla G; Wang F; Zhu M; Li L; Li P; Xie Q; Lv X; Yu J; Wang G; Wan H; Richeldi L; Luo F
BMC Pulm Med; 2023 Mar; 23(1):90. PubMed ID: 36941622
[TBL] [Abstract][Full Text] [Related]
30. Quantitative evaluation of disease severity in connective tissue disease-associated interstitial lung disease by dual-energy computed tomography.
Chen L; Zhu M; Lu H; Yang T; Li W; Zhang Y; Xie Q; Li Z; Wan H; Luo F
Respir Res; 2022 Mar; 23(1):47. PubMed ID: 35248040
[TBL] [Abstract][Full Text] [Related]
31. Biomarkers in connective tissue disease-associated interstitial lung disease.
Bonella F; Costabel U
Semin Respir Crit Care Med; 2014 Apr; 35(2):181-200. PubMed ID: 24668534
[TBL] [Abstract][Full Text] [Related]
32. Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study.
Pan L; Liu Y; Sun R; Fan M; Shi G
Clin Dev Immunol; 2013; 2013():121578. PubMed ID: 24171031
[TBL] [Abstract][Full Text] [Related]
33. Serum B-cell activating factor and lung ultrasound B-lines in connective tissue disease related interstitial lung disease.
Wang Y; Xie X; Zheng S; Du G; Chen S; Zhang W; Zhuang J; Lin J; Hu S; Zheng K; Mikish A; Xu Z; Zhang G; Gargani L; Bruni C; Hoffmann-Vold AM; Matucci-Cerinic M; Furst DE
Front Med (Lausanne); 2022; 9():1066111. PubMed ID: 36590969
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of computer-based computer tomography stratification against outcome models in connective tissue disease-related interstitial lung disease: a patient outcome study.
Jacob J; Bartholmai BJ; Rajagopalan S; Brun AL; Egashira R; Karwoski R; Kokosi M; Wells AU; Hansell DM
BMC Med; 2016 Nov; 14(1):190. PubMed ID: 27876024
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D deficiency and reduced lung function in connective tissue-associated interstitial lung diseases.
Hagaman JT; Panos RJ; McCormack FX; Thakar CV; Wikenheiser-Brokamp KA; Shipley RT; Kinder BW
Chest; 2011 Feb; 139(2):353-360. PubMed ID: 20688927
[TBL] [Abstract][Full Text] [Related]
36. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
[TBL] [Abstract][Full Text] [Related]
37. Computed Tomography-Based Deep Learning Model for Assessing the Severity of Patients With Connective Tissue Disease-Associated Interstitial Lung Disease.
Su N; Hou F; Zheng W; Wu Z; E L
J Comput Assist Tomogr; 2023 Sep-Oct 01; 47(5):738-745. PubMed ID: 37707403
[TBL] [Abstract][Full Text] [Related]
38. Serum KL-6 and the mortality of patients with connective tissue disease-associated interstitial lung disease: A meta-analysis.
Hong M; Yin X; Yan W; Guo W; Liu H; Yang H
Biomol Biomed; 2024 May; ():. PubMed ID: 38743787
[TBL] [Abstract][Full Text] [Related]
39. Serum KL-6 and surfactant protein-D as monitoring and predictive markers of interstitial lung disease in patients with systemic sclerosis and mixed connective tissue disease.
Yamakawa H; Hagiwara E; Kitamura H; Yamanaka Y; Ikeda S; Sekine A; Baba T; Okudela K; Iwasawa T; Takemura T; Kuwano K; Ogura T
J Thorac Dis; 2017 Feb; 9(2):362-371. PubMed ID: 28275485
[TBL] [Abstract][Full Text] [Related]
40. Pirfenidone inhibits cell fibrosis in connective tissue disease-associated interstitial lung disease by targeting the TNF-α/STAT3/KL6 pathway.
Zuo Y; Liu J; Xu H; Li Y; Tao R; Zhang Z
J Thorac Dis; 2022 Jun; 14(6):2089-2102. PubMed ID: 35813760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
